Home/DermTech/Jeremy Teraoka
JT

Jeremy Teraoka

Head of Finance

DermTech

Therapeutic Areas

DermTech Pipeline

DrugIndicationPhase
DermTech Melanoma Test (2-GEP)Early detection of melanoma in equivocal pigmented lesionsCommercial